Myriad Genetics, Inc.

NASDAQ:MYGN   3:59:58 PM EDT
28.23
+1.37 (+5.10%)
Mergers / Acquisitions

Myriad Genetics Signs Definitive Agreement To Sell Myriad Autoimmune’S Vectra Testing Business To Labcorp In A $150 Mln Deal

Published: 05/03/2021 12:29 GMT
Myriad Genetics, Inc. (MYGN) - Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp.
Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp.
Myriad Genetics Inc - Deal for $150 Million in Cash.